Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by Barclays PLC

Barclays PLC reduced its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 62.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 129,133 shares of the company’s stock after selling 211,901 shares during the period. Barclays PLC’s holdings in Surgery Partners were worth $4,164,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SGRY. Quarry LP lifted its holdings in shares of Surgery Partners by 133.1% in the 2nd quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after purchasing an additional 1,760 shares during the last quarter. KBC Group NV increased its position in Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after buying an additional 576 shares during the period. Point72 Asia Singapore Pte. Ltd. lifted its stake in Surgery Partners by 747.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock valued at $124,000 after buying an additional 3,379 shares during the last quarter. Creative Planning acquired a new stake in shares of Surgery Partners in the third quarter valued at approximately $258,000. Finally, Versor Investments LP acquired a new stake in shares of Surgery Partners in the third quarter valued at approximately $271,000.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on SGRY shares. JPMorgan Chase & Co. dropped their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a report on Tuesday, December 3rd. Benchmark reissued a “buy” rating and set a $50.00 price target on shares of Surgery Partners in a research note on Monday, August 26th. UBS Group started coverage on shares of Surgery Partners in a research note on Monday, October 14th. They issued a “buy” rating and a $38.00 price objective on the stock. Royal Bank of Canada reduced their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. Finally, Macquarie reissued an “outperform” rating and issued a $34.00 price objective on shares of Surgery Partners in a research report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $36.56.

Surgery Partners Price Performance

NASDAQ SGRY opened at $21.22 on Monday. The stock has a market capitalization of $2.70 billion, a P/E ratio of -44.21, a P/E/G ratio of 17.40 and a beta of 2.58. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The business’s fifty day moving average is $25.99 and its two-hundred day moving average is $27.77. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $35.29.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same quarter in the previous year, the business posted $0.15 earnings per share. The company’s revenue was up 14.3% compared to the same quarter last year. On average, research analysts forecast that Surgery Partners, Inc. will post 0.71 earnings per share for the current fiscal year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.